JP Morgan analyst Domingos Falavina upgrades XP (NASDAQ:XP) from Neutral to Overweight.
Wells Fargo Maintains Overweight on Centene, Lowers Price Target to $88
Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Overweight and lowers the price target from $93 to $88.